Prestige Consumer Healthcare
312 hedge funds and large institutions have $3.72B invested in Prestige Consumer Healthcare in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 99 increasing their positions, 122 reducing their positions, and 19 closing their positions.
5,400% more call options, than puts
Call options by funds: $385K | Put options by funds: $7K
142% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 19
19% more capital invested
Capital invested by funds: $3.14B → $3.72B (+$588M)
8% more funds holding
Funds holding: 288 → 312 (+24)
0.16% more ownership
Funds ownership: 103.22% → 103.38% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 122
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$82.2M |
| 2 |
Morgan Stanley
New York
|
+$27.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.4M |
| 5 |
DIA
Dana Investment Advisors
Waukesha,
Wisconsin
|
+$7.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$22.6M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.6M |
| 3 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$14.6M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$11.1M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$9.7M |
PBH Hedge Fund Activity: Q1 2024 in Review
312 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2024, worth a combined $3.72B — up 19% from $3.14B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new PBH positions and 19 closed out — a net gain of 27 holders — while 99 added to existing stakes and 122 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $82.2M. The largest seller was BlackRock, cutting an estimated $22.6M.
- 312 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2024, up from 288 in Q4 2023.
- Funds reported $3.72B of Prestige Consumer Healthcare stock for Q1 2024, up 19% quarter-over-quarter.
- 46 funds opened new Prestige Consumer Healthcare positions in Q1 2024 and 19 closed out, a net change of +27 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2024 was Victory Capital Management, an estimated $82.2M added.
- The largest Prestige Consumer Healthcare seller in Q1 2024 was BlackRock, an estimated $22.6M sold.
Based on aggregated 13F filings for Q1 2024.